Chugai Pharmaceutical Co's market cap is currently ―. The company's EPS TTM is $1.561; its P/E ratio is ―; and it has a dividend yield of 1.15%. Chugai Pharmaceutical Co is scheduled to report earnings on January 30, 2025, and the estimated EPS forecast is $0.38. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Income Statement	-
Total Revenue	$ 225.28B	$ 235.61B	$ 360.56B	$ 322.27B	$ 287.26B
Gross Profit	$ 156.19B	$ 155.79B	$ 246.13B	$ 211.71B	$ 183.07B
EBIT	$ 95.05B	$ 100.73B	$ 186.22B	$ 138.45B	$ 119.70B
EBITDA	$ 95.05B	$ 100.73B	$ 186.22B	$ 138.45B	$ 119.70B
Net Income Common Stockholders	$ 67.80B	$ 72.38B	$ 131.78B	$ 98.84B	$ 86.02B
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 545.29B	$ 592.24B	$ 431.82B	$ 471.97B	$ 396.65B
Total Assets	$ 1.70T	$ 1.63T	$ 1.58T	$ 1.54T	$ 1.35T
Total Debt	$ ―	$ ―	$ ―	$ ―	$ ―
Net Debt	$ ―	$ ―	$ ―	$ ―	$ ―
Total Liabilities	-	-	-	-	-
Stockholders Equity	$ 1.31T	$ 1.31T	$ 1.24T	$ 1.19T	$ 1.09T
Cash Flow	-
Free Cash Flow	$ 16.27B	$ 159.86B	$ 35.75B	$ 87.11B	$ 56.52B
Operating Cash Flow	$ 25.19B	$ 173.39B	$ 72.54B	$ 94.96B	$ 81.67B
Investing Cash Flow	$ -47.45B	$ -42.55B	$ -33.98B	$ -17.17B	$ -25.16B
Financing Cash Flow	$ -63.98B	$ -2.44B	$ -76.87B	$ -2.98B	$ -51.04B

Currency in USD

Chugai Pharmaceutical Co Earnings and Revenue History

Income Statement >

Chugai Pharmaceutical Co Debt to Assets

Balance Sheet >

Chugai Pharmaceutical Co Cash Flow

Cash Flow >

Chugai Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing